Pain Management Devices Market

Global Pain Management Devices Market is valued at USD 4779.1 Million in 2020 and is expected to reach USD 7840.1 Million by 2027 with a CAGR of 8.6% over the forecast period.

Global Pain Management Devices Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027: The increasing prevalence of musculoskeletal disorders, such as arthritis, osteoarthritis, orthopedic degenerative disorders, and rheumatoid arthritis, and a resultant rise in the cases of chronic pain and inability to carry out routine tasks are some of the major factors driving the market growth.

Scope of the Global Pain Management Device Report:

Pain due to tissue damage or illness is an unpleasant sensitive and emotional experience. It is caused by various diseases such as injury and osteoarthritis, acute arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcers, fibromyalgia, and cancer. It can be classified on the basis of duration as acute pain and acute pain. Acute pain is a sudden onset of pain that lasts for a long time. Acute pain is mainly caused by aging conditions of bones and joints and nerve damage and injury. Pain is managed by a specific set of medications or devices to treat pain. Furthermore, transcutaneous electrical nerve stimulators, neuro-stimulators, analgesic infusion pumps, and radiofrequency ablators are some of the pain management tools.

Most of these devices block the pain gate system to get to the pain signals in the brain. Radiofrequency amplifiers destroy nerves by generating heat to block pain signals, just as neuro-stimulator devices use a mild frequency current to interrupt the state of pain signals. These devices help treat a variety of painful conditions such as cancer, musculoskeletal injury, and neuropathic pain. Pain management devices help to reduce the risk of long-term drugs, non-steroidal anti-inflammatory drugs, and other painkillers.

The outbreak of COVID-19 has affected the growth of the global pain management device market. Huge numbers of emergency clinics and hospitals have seen a drop in the number of patient visits during the COVID-19 outbreak eventually lessening client contact. Also, as most chronic pain management is viewed as non-critical, the mental strength of patients has been unfavorably influenced during the pandemic. The COVID-19 pandemic has left the patients with intense pain untreated, as the patients will, in general, keep away from clinic visits in fear of contamination, and then again, the social separation during the pandemic could lead to depression and anxiety among the patients. Subsequently, the COVID-19 pandemic is relied upon to have a direct and indirect impact on the pain management market all around the world. According to the Indian Journal of Anesthesia, COVID-19 has shown a negative impact on pain clinics, including interventional pain management procedures.

Pain Management Device Companies:

Some of the key players in the global pain management devices market are Medtronic plc. (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), DJO Global LLC., Johnson & Johnson (Codman And Shurtleff, Inc.,), Kimberly Clark Corporation, Pfizer, Inc., and Stryker Corp., and others.

Global Pain Management Devices Market Segmentation:

Global pain management devices market report is segmented on the basis of type, mode of purchase, application and region & country level. Based upon type, the global pain management devices market is classified into ablation devices, neuromodulation devices and analgesic infusion pumps. Based upon application, the market is divided into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and others. Based upon mode of purchase, the global pain management devices market is divided into over-the-counter devices and prescription-based devices.

By Type:

• Neuromodulation Devices
• Ablation Devices
• Analgesic Infusion Pumps

By Application:

• Neuropathic Pain
• Cancer Pain
• Facial Pain and Migraine
• Musculoskeletal Pain
• Others

By Mode of Purchase:

• Over-the-counter Devices
• Prescription-based Devices
• Others

News: Boston Scientific has Launched WaveWriter Alpha Spinal Cord Stimulator Systems in the U.S.

On January 14^th, 2021, Boston Scientific has announced a release of the WaveWriter Alpha portfolio of medulla spinalis Stimulator (SCS) systems. The unified portfolio of 4 MRI conditional, Bluetooth-enabled rechargeable and non-rechargeable implantable pulse generators (IPGs) provides uncompromised personalization, and for the primary time in SCS, Fast-acting Sub-perception Therapy (FAST) designed to provide profound paresthesia-free pain relief in just a few minutes. The systems are supported by the Cognita Solutions suite of digital tools for patients and physicians.

The Increasing Incidences Chronic Diseases such as Cancer, Diabetic Neuropathy, and Osteoarthritis are Some of the Major Factors Driving the Market Growth

The growing incidences of chronic diseases such as cancer, diabetic neuropathy, and osteoarthritis are some of the major factors driving the demand for pain management devices. The increase in the number of surgical procedures and the rising elderly population is also supplementing the growth of global pain management devices market. Rising awareness about the highly proven efficiency of pain management equipment for the treatment of acute pain and the availability of devices for pain management are also fostering the demand for pain management equipment. In addition, population growth established reimbursement conditions for spinal cord stimulation (SCS) equipment in developed countries; costs for health, research and development activities, development of novel pain management equipment, and increase in health costs are also positively impacting the pain management devices market.

However, the high cost associated with equipment and procedures, the existence of gaps in the scope and treatment of pain, and the lack of awareness about the availability and use of pain management tools may hinder the market growth. Increasing the availability of alternative therapies for pain management and the stringent regulatory guidelines delaying the adoption of novel equipment may pose a challenge in the pain management devices market. In spite of that, the expansion of the foundation of pain management clinics/centers globally, strict regulations to limit pain killer prescriptions, and strong production pipelines for pain management tools may create more beneficial opportunities for players in the pain management equipment market.

North America is Anticipated to Dominate the Global Pain Management Devices Market

North America is expected to dominate the global pain management devices market due to the highly developed health are infrastructure, easy availability of the products, early adoption of new technologies, and presence of key players in this region. In addition, government initiatives such as precision medicine and affordable care lows, coupled with carefully planned reimbursement policies, contributed to the market growth in this region. Furthermore, increasing awareness and high purchasing power parity are boosting the demand for pain management devices in this region.

The Asia-Pacific is expected to witness the fastest growth in the global pain management devices market. This region has become an attractive destination for companies engaged in the manufacturing of pain management devices. The high growth in this regional segment can be attributed to a number of factors, including the growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and raising awareness about the safety and efficacy of pain management devices.       

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

South America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2021 - 2027
Market Size in 2020:	USD 4779.1 Million
Base year considered	2020
Forecast Period CAGR %:	8.6%
Market Size Expected in 2027:	USD 7840.1 Million
Tables, Charts & Figures:	175
Pages	200
Pain Management Device Companies:	Medtronic plc. (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), DJO Global LLC., Johnson & Johnson (Codman And Shurtleff, Inc.,), Kimberly Clark Corporation, Pfizer, Inc., and Stryker Corp., and others.
Segments Covered	By Type, By Application, By Mode of Purchase
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits of Global Pain Management Devices Report–

• Global Pain Management Devices report covers in-depth historical and forecasts analysis.
• Global Pain Management Devices research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Pain Management Device Companies, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global Pain Management Devices report helps to identify opportunities in the marketplace.
• Global Pain Management Devices report covers extensive analysis of emerging trends and competitive landscape.